糖尿病患者的COVID-19:理解不良结局的原因
自中国最初COVID-19暴发以来,糖尿病患者因感染后预后较差而备受关注。初期报告主要涉及2型糖尿病患者,但近期调查显示1型糖尿病患者同样面临重症COVID-19风险。糖尿病患者预后较差的原因可能是多因素的,反映了糖尿病的综合征性质。年龄、性别、种族、高血压和心血管疾病等合并症、肥胖以及促炎和促凝血状态都可能促成不良结局风险。降糖药物和抗病毒治疗可调节风险,但其使用限制及与COVID-19治疗的潜在相互作用应仔细评估。最后,严重急性呼吸综合征冠状病毒2感染本身可能是糖尿病患者的恶化因素,因为它通过对β细胞功能的直接负面影响诱发急性代谢并发症。这些对β细胞功能的影响还可能导致糖尿病患者发生糖尿病酮症酸中毒、糖尿病史未知者入院时高血糖以及潜在的新发糖尿病。
要点
- 糖尿病患者感染COVID-19后预后较差,原因涉及年龄、合并症、肥胖及促炎促凝状态等多因素。
- 降糖药和抗病毒治疗可调节风险,但需评估使用限制及与COVID-19治疗的相互作用。
- SARS-CoV-2感染可直接损害β细胞功能,诱发糖尿病酮症酸中毒、入院高血糖及潜在新发糖尿病。
核心结论
- 糖尿病患者COVID-19预后较差的原因可能是多因素的,反映了糖尿病的综合征性质。
- SARS-CoV-2感染本身可能通过直接负向影响β细胞功能而成为糖尿病患者的恶化因素。
研究设计与样本
- 本文为综述,检索范围未在原文中报告。
主要发现
- 年龄、性别、种族、高血压和心血管疾病等合并症、肥胖以及促炎和促凝血状态都可能促成不良结局风险。
- 降糖药物和抗病毒治疗可调节风险,但其使用限制及与COVID-19治疗的潜在相互作用应仔细评估。
- SARS-CoV-2感染对β细胞功能的影响可能导致糖尿病患者发生糖尿病酮症酸中毒、糖尿病史未知者入院时高血糖以及潜在的新发糖尿病。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Since the initial COVID-19 outbreak in China, much attention has focused on people with diabetes because of poor prognosis in those with the infection. Initial reports were mainly on people with type 2 diabetes, although recent surveys have shown that individuals with type 1 diabetes are also at risk of severe COVID-19. The reason for worse prognosis in people with diabetes is likely to be multifactorial, thus reflecting the syndromic nature of diabetes. Age, sex, ethnicity, comorbidities such as hypertension and cardiovascular disease, obesity, and a pro-inflammatory and pro-coagulative state all probably contribute to the risk of worse outcomes. Glucose-lowering agents and anti-viral treatments can modulate the risk, but limitations to their use and potential interactions with COVID-19 treatments should be carefully assessed. Finally, severe acute respiratory syndrome coronavirus 2 infection itself might represent a worsening factor for people with diabetes, as it can precipitate acute metabolic complications through direct negative effects on β-cell function. These effects on β-cell function might also cause diabetic ketoacidosis in individuals with diabetes, hyperglycaemia at hospital admission in individuals with unknown history of diabetes, and potentially new-onset diabetes.
引用
- Apicella M, Campopiano MC, Mantuano M, et al. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. 2020. PMID: 32687793. doi:10.1016/S2213-8587(20)30238-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。